Search Results for ''

published presentations and documents on DocSlides.

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by blindnessinfluenced

proceedings from the live CME event and may includ...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by chaptoe

proceedings from the live CME event and may includ...

ASCO 2012 Review Gynecologic Cancer

ASCO 2012 Review Gynecologic Cancer

by welnews

Nelson Teng, M.D., Ph.D.. Director, Gynecologic On...

Behandeling van het recidief ovariumcarcinoom

Behandeling van het recidief ovariumcarcinoom

by sandsomber

Ignace Vergote MD PhD FACS FSPS. Chairman, Leuven ...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

by spottletoefacebook

Grazia Arpino. Università di Napoli Federico II. ...

Romidepsin in Association with CHOP in Patients with Peripheral T

Romidepsin in Association with CHOP in Patients with Peripheral T

by accompanypepsi

-Cell . Lymphoma: Final Results of the Phase . Ib....

Ovarian cancer with update from ASCO 2013

Ovarian cancer with update from ASCO 2013

by karlyn-bohler

Siew. . wei. . wong. Oncology registrar. Epidem...

Ovarian Cancer Incidence/Mortality

Ovarian Cancer Incidence/Mortality

by kittie-lecroy

Improvement in 5 Year Survival:. Race. 1975. 1989...

NEw developments IN gynecological Oncology

NEw developments IN gynecological Oncology

by cheryl-pisano

highlights from the. EUROPEAN . society . of med...

Overall Survival Benefit of

Overall Survival Benefit of

by tatyana-admore

Obinutuzumab. Over Rituximab when Combined with ...

Targeting endocrine-resistance pathways in breast cancer

Targeting endocrine-resistance pathways in breast cancer

by alexa-scheidler

Targeting endocrine-resistance pathways in breas...

The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016

The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016

by phoebe-click

The Impending D eath of Cancer: A Herculean Task...

Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP

Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP

by ellena-manuel

Pharmacist Focus on BTK Inhibitors Moderator Shil...

PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update

PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update

by ellena-manuel

Program Overview . Discussion Outline. DNA Repair...

A1 Using a Positive Family Support Screener to Inform Tiered Supports

A1 Using a Positive Family Support Screener to Inform Tiered Supports

by natalia-silvester

Strand:. Applied Evaluation. Recommended Experie...

Indolent Non-Hodgkin L

Indolent Non-Hodgkin L

by danika-pritchard

ymphoma. Sobia Ozair. March 8, 2017. MD Anderson ...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

by debby-jeon

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)

Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)

by ellena-manuel

Swiss Group for Clinical Cancer Research (SAKK). ...

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

by sherrill-nordquist

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

Common Knee Injuries Meniscus Tears

Common Knee Injuries Meniscus Tears

by celsa-spraggs

Knee twisted suddenly. One or both menisci become...

Exemplary Practices and Your

Exemplary Practices and Your

by olivia-moreira

Evaluation. . Report. Migrant Education Program ...

Case Discussion: Second

Case Discussion: Second

by celsa-spraggs

Opinion. 55 year-old woman with . recurrent . ova...

State of the Art in BRCA

State of the Art in BRCA

by ellena-manuel

-Mutated Ovarian Cancer. This program will includ...

Jon Trent, MD, PhD Professor of Medicine

Jon Trent, MD, PhD Professor of Medicine

by jane-oiler

Sarcoma . Medical Oncology. The University of . M...

Where we are with targeted

Where we are with targeted

by stefany-barnette

therapies . for . cholangiocarcinoma. Professor J...

by myesha-ticknor

sorafenib. in patients with . desmoid. -type . f...

Scalable I/O-Aware Job Scheduling for

Scalable I/O-Aware Job Scheduling for

by lois-ondreau

Burst Buffer Enabled HPC Clusters. Chunxiao. Lia...

Immunotherapy for

Immunotherapy for

by sherrill-nordquist

High-Risk and Metastatic Melanoma. Timothy M. Kuz...

Please note, these are the actual video-recorded proceeding

Please note, these are the actual video-recorded proceeding

by luanne-stotts

Moderator. Neil Love, MD. Mollie Moran, MSN, CNP,...

Changing the Ecology of Youth Development

Changing the Ecology of Youth Development

by liane-varnes

Empowering Schools and Families by Coordinating ....

PFs, SOs & DAFs, oh my!!!

PFs, SOs & DAFs, oh my!!!

by pamella-moone

Christy . Butler Eckoff. , J.D., LL.M, CAP, CFRE....

by pasty-toler

MD. The Evolving Treatment Landscape in NSCLC: Co...

L’algoritmo terapeutico

L’algoritmo terapeutico

by calandra-battersby

attraverso . i . c. asi clinici. Giuseppe . Valma...

by mitsue-stanley

Matlab. 27-. 750. Texture, Microstructure & ....

by tawny-fly

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

HIGH PERFORMANCE COMPUTING

HIGH PERFORMANCE COMPUTING

by karlyn-bohler

ENVIRONMENT. . The High Performance Computing en...

by alida-meadow

treatments. in WT . pts. : . which. . opportuni...

Company proﬁ leProject name: Songwe Hill Rare Earths ProjectP

Company proﬁ leProject name: Songwe Hill Rare Earths ProjectP

by min-jolicoeur

PFS well advanced, favourable topography, simple w...

Multiple Myeloma – Is It Now Curable?

Multiple Myeloma – Is It Now Curable?

by celsa-spraggs

Andrzej . J. . Jakubowiak, MD, PhD. Director, Mye...

by phoebe-click

. Highlights from the Annual Clinical Meeting. G...